Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 138 Lymphoma, Non-Hodgkin 84 Lymphoma, Large B-Cell, Diffuse 83 Small Cell Lung Carcinoma 78 Hodgkin Disease 61 Precursor Cell Lymphoblastic Leukemia-Lymphoma 59 Leukemia 57 Burkitt Lymphoma 56 Lung Neoplasms 49 Lymphoma, Follicular 47 Lymphoma, Mantle-Cell 44 Leukemia, Myeloid, Acute 41 Lymphoma, Large-Cell, Immunoblastic 40 Multiple Myeloma 33 Leukemia, Lymphocytic, Chronic, B-Cell 33 Carcinoma, Non-Small-Cell Lung 30 Recurrence 26 Neuroblastoma 25 Lymphoma, B-Cell, Marginal Zone 25 Central Nervous System Neoplasms 24 Ovarian Neoplasms 18 Sarcoma 17 Brain Neoplasms 17 Dendritic Cell Sarcoma, Interdigitating 16 Congenital Abnormalities 16 Lymphoma, Large-Cell, Anaplastic 15 Breast Neoplasms 15 Testicular Neoplasms 14 Neoplasms, Plasma Cell 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

Oxaliplatin 166 Capecitabine 112 Fluorouracil 95 Docetaxel 85 Cisplatin 84 S 1 (combination) 83 Leucovorin 64 Paclitaxel 58 Irinotecan 56 pembrolizumab 36 sintilimab 34 Trastuzumab 34 apatinib 30 Bevacizumab 21 Surgical Procedures, Operative 19 Radiotherapy 19 titanium silicide 17 camrelizumab 17 Nivolumab 17 Ramucirumab 16 Drug Therapy 15 Hyperthermic Intraperitoneal Chemotherapy 14 Folfox protocol 14 Epirubicin 14 tislelizumab 13 Neoadjuvant Therapy 12 Cetuximab 12 XELOX 10 Tegafur 10 Carboplatin 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Stomach Neoplasms × Etoposide × Clear all

NCT02949258 2016-10-31

NCT-B4

Jinling Hospital, China

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡